Source: BioPortfolio

Profectus Biosciences: CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine

OSLO Norway and BALTIMORE and GAITHERSBURG Md. May 24 2018 GLOBE NEWSWIRE CEPIthe Coalition for Epidemic Preparedness Innovationstoday announced a collaboration with Profectus BioSciences Inc. and Emergent BioSolutions Inc. NYSEEBS under which Profectus...

Read full article »
Profectus Biosciences's Competitors | Profectus Biosciences's News | Profectus Biosciences's Financials
Stay up-to-date with the latest news on Profectus Biosciences
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Jeffrey N. Meshulam's photo - President of Profectus Biosciences

President

Jeffrey N. Meshulam

CEO Approval Rating

87/100

Read more
Stay up-to-date with the latest news on Profectus Biosciences